Home
Resources
Publications
[Anti-lithogenic Effect of Meloxicam in Experimental Nephrolithiasis]

[Anti-lithogenic Effect of Meloxicam in Experimental Nephrolithiasis]

A Iu Zharikov, Ia F Zverev, V M Briukhanov, V V Lampatov

Eksp Klin Farmakol. 2012;75(3):14-7.

PMID: 22679747

Abstract:

Experiments performed on 23 male rats, were divided into 2 groups. Animals in the control received group 1% solution of ethylene glycol (EG) as a drink during 6 weeks. In the test group, EG was also introduced for 6 weeks, and meloxicam was administered in a dose of 2.5 mg/kg from the 4th week. Every 7 days, daily urine was analyzed for the concentrations of oxalate, phosphate, and calcium and for the activity of urothelium injury marker enzymes includng lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), and N-acetyl-beta-D-glucose aminidase (NAG). In addition, sections of the rats kidney were used to detect calcium deposits by histochemical Van Koss method. The treatment of experimental nephrolithiasis by meloxicame led to simplification of pathology, as indicated by a significant reduction in the urine oxalate and calcium concentrations and a pronounced decrease in the activity of all marker enzymes (LDH, GGT, NAG).This was confirmed by morphological studies, which detected very significant reduction in both number and size of calcium deposits.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AS271844	Acetyl norfentanyl-13C6 oxalate solution			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: